Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease

 

Clinical Updates in Drug-Eluting Technologies for the Treatment of Peripheral Vascular Disease
17:00

William Gray

Two-Year Efficacy and Safety Results from the IMPERIAL Randomized Study: Polymer-Coated Drug-Eluting Stents vs. Polymer-free Drug-Coated Stents

  • 1,535 views
  • September 3, 2021
  • 4
04:50

NY Endovascular Summit

COMPARE-Pilot RCT: 2-Year Results of RANGER DCB vs. IN.PACT DCB

FEATURING Dierk Scheinert
  • 463 views
  • September 21, 2020
12:23

KC Vascular Symposium 2022

Drug Eluting Balloons and Stents for PAD: Are They Safe?

FEATURING Brandon Custer
  • 489 views
  • May 12, 2022
10:58

NY Endovascular Summit

DCB in Real-World Lesions: What Is the Data?

FEATURING Fabrizio Fanelli
  • 798 views
  • December 2, 2021
  • 3
12:45

NY Endovascular Summit

My Algorithm for Definitive Therapy in Severely Calcific SFA CTO: DES, DCB, and BMS

FEATURING Brian DeRubertis
  • 1,155 views
  • December 1, 2021
  • 5
17:27

ARCH Advanced Revascularization Symposium

Paclitaxel or Limus: What Is the Future in Drug Eluting Therapies?

FEATURING Craig Walker
  • 1,528 views
  • June 7, 2022
  • 11
19:38

NY Endovascular Summit

Drug Coated Balloons and Mortality in Peripheral Vascular Interventions

FEATURING Eric Secemsky
  • 791 views
  • November 24, 2022
  • 2
09:47

NY Endovascular Summit

Therapy of Choice for In-Stent Restenosis

FEATURING Elizabeth Genovese
  • 1,272 views
  • November 23, 2022
  • 5
10:46

NY Endovascular Summit

DCB vs. DES in Real World Lesions: How Do I Choose?

FEATURING Kenneth Rosenfield
  • 889 views
  • November 22, 2022
  • 6